Methyl thieno[3,2-d]pyrimidine-4-carboxylate

Catalog No.: 
ACVUWJ624
CAS No.: 
1029144-47-5
Molecular Formula: 
C8H6N2O2S
Molecular Weight: 
194.21
Methyl thieno[3,2-d]pyrimidine-4-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$195.00InquiryInquiry
250mg98%$390.00InquiryInquiry
1g98%$976.00InquiryInquiry
5g98%$2338.00InquiryInquiry
10g98%$3898.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl thieno[3,2-d]pyrimidine-4-carboxylate
IUPAC Namemethyl thieno[3,2-d]pyrimidine-4-carboxylate
MDL No.MFCD22566149
Molecular FormulaC8H6N2O2S
Molecular Weight194.21
SMILESO=C(C1=C2C(C=CS2)=NC=N1)OC
InChI KeyKJQJFAKBXWTHLA-UHFFFAOYSA-N
SynonymMethyl thieno[3,2-d]pyrimidine-4-carboxylate;Thieno[3,2-d]pyrimidine-4-carboxylic acid, methyl ester
CAS No.1029144-47-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACVUWJ624 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVUWJ624 route product structure diagram
    ACVUWJ6241029144-47-5
Inquiry

2. ACVUWJ624 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVUWJ624 route product structure diagram
    ACVUWJ6241029144-47-5
Inquiry

3. ACVUWJ624 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVUWJ624 route product structure diagram
    ACVUWJ6241029144-47-5
Inquiry

Comments (0)